Adma Biologics, Inc.

GRIMES & Co WEALTH MANAGEMENT, LLC ADMA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/3/2026

Shares

13,447

Value ($000)

245

Weight

0.0%

2020 Q3 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/3/2026	245	0.0%	13,447	12/31/2025
2025 Q3	10/27/2025	200	0.0%	13,674	9/30/2025
2025 Q2	7/22/2025	249	0.0%	13,674	6/30/2025
2025 Q1	4/17/2025	430	0.0%	21,690	3/31/2025
2024 Q4	1/21/2025	391	0.0%	22,812	12/31/2024
2024 Q3	10/22/2024	465	0.0%	23,285	9/30/2024
2024 Q2	7/22/2024	447	0.0%	39,987	6/30/2024
2024 Q1	4/17/2024	299	0.0%	45,267	3/31/2024
2023 Q4	1/24/2024	205	0.0%	45,267	12/31/2023
2023 Q3	10/19/2023	162	0.0%	45,267	9/30/2023
2023 Q2	7/19/2023	167	0.0%	45,267	6/30/2023
2023 Q1	4/20/2023	150	0.0%	45,267	3/31/2023
2022 Q4	1/25/2023	207	0.0%	53,314	12/31/2022
2022 Q3	10/28/2022	130	0.0%	53,314	9/30/2022
2022 Q2	7/22/2022	106	0.0%	53,314	6/30/2022
2022 Q1	5/6/2022	98	0.0%	53,314	3/31/2022
2021 Q4	2/1/2022	76	0.0%	54,186	12/31/2021
2021 Q3	11/8/2021	61	0.0%	54,186	9/30/2021
2021 Q2	8/4/2021	87	0.0%	54,186	6/30/2021
2021 Q1	5/12/2021	90	0.0%	51,070	3/31/2021
2020 Q4	2/2/2021	69	0.0%	35,309	12/31/2020
2020 Q3	11/12/2020	80	0.0%	33,500	9/30/2020